Mitral annuloplasty ring migration

Nauman Hussain1, Cheng Ting Lin2, Claire Brookmeyer2

  • 1¹Department of Radiology, Johns Hopkins University School of Medicine, Baltimore, MD, USA. nhussa13@jhmi.edu.

Insights

Mitral annuloplasty ring dehiscence is a rare complication. Migrated rings can cause severe vascular issues, including aortic rupture, posing management challenges.

Area of Science:

  • Cardiovascular Surgery
  • Medical Device Complications
  • Surgical Outcomes

Background:

  • Mitral annuloplasty is a common surgical procedure to treat mitral valve regurgitation.
  • Ring dehiscence, the separation of the annuloplasty ring from the native tissue, is a rare but known post-operative complication.
  • While rare, the migration of dehiscent annuloplasty rings can lead to life-threatening vascular events.

Observation:

  • This case report details a patient experiencing dehiscence of a mitral annuloplasty ring.
  • The dehiscent ring subsequently migrated, leading to significant vascular complications.
  • The patient presented with severe consequences requiring complex management.

Findings:

  • Annuloplasty ring dehiscence is an uncommon complication following mitral valve repair surgery.
  • Ring migration is an exceptionally rare sequela of dehiscence, with potentially catastrophic vascular consequences such as aortic rupture and pseudoaneurysm formation.
  • Management of these high-risk patients with migrated annuloplasty rings is challenging and requires careful consideration.

Implications:

  • This case underscores the importance of recognizing rare complications associated with mitral annuloplasty rings.
  • It highlights the potential for severe vascular injury due to ring migration, emphasizing the need for vigilance in post-operative monitoring.
  • The management strategies discussed offer insights for handling similar complex cases in cardiovascular surgery.

Related Concept Videos

Mitral Valve Prolapse I: Introduction01:27

Mitral Valve Prolapse I: Introduction

IntroductionThe mitral valve, one of the heart's four valves, regulates blood flow. These valves have flaps that open and close to direct blood properly through the heart and body. During each heartbeat, the flaps open for blood to pass through and seal shut to prevent backflow. Specifically, the mitral valve opens to allow blood flow from the heart's upper left chamber to the lower left chamber. It then closes securely as the lower left chamber contracts to pump blood to the body, preventing...
Mitral Valve Prolapse II: Assessment and Management01:22

Mitral Valve Prolapse II: Assessment and Management

IntroductionA range of clinical features characterizes Mitral Valve Prolapse (MVP), but it is important to note that many individuals with MVP are asymptomatic and may remain so throughout their lives. For those who do exhibit symptoms, the following are the key clinical features:Palpitations: This is a common symptom where individuals feel an irregular or rapid heartbeat. Palpitations in MVP are often due to arrhythmias such as premature ventricular contractions or supraventricular tachycardia.
Mitral Regurgitation I: Introduction01:20

Mitral Regurgitation I: Introduction

Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
Mitral Regurgitation III: Medical Management01:25

Mitral Regurgitation III: Medical Management

Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...